Identification of ALP+/CD73+ defining markers for enhanced osteogenic potential in human adipose-derived mesenchymal stromal cells by mass cytometry.
Daisy D CanepaElisa A CasanovaEirini ArvanitiVinko TosevskiSonja MärsmannBenjamin EggerschwilerSascha HalvachizadehJohanna BuschmannAndré A BarthJan A PlockManfred ClaassenHans-Christoph PapePaolo CinelliPublished in: Stem cell research & therapy (2021)
The data obtained reveal, at single-cell level, the heterogeneity of AD-MSCs from several donors and highlight how cellular composition impacts the osteogenic differentiation capacity. The marker combination (ALP/CD73) can not only be used to assess the differentiation potential of undifferentiated AD-MSC preparations, but also could be employed to prospectively enrich AD-MSCs from the stromal vascular fraction of human adipose tissue for therapeutic applications.